Screener
Aclaris Therapeutics ACRS Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from Aclaris Therapeutics’s reported figures.
Based on trailing twelve months.
The source filing: Aclaris Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:31 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-092065
FAQ
- What is Aclaris Therapeutics's net margin?
- Aclaris Therapeutics (ACRS) reported net margin of -921.5% in Q2 2026.
- How has Aclaris Therapeutics's net margin changed year-over-year?
- Aclaris Therapeutics's net margin decreased by 14.9% year-over-year, from -802% to -921.5%.
- What is the long-term trend for Aclaris Therapeutics's net margin?
- Over 5 years (2020 to 2025), Aclaris Therapeutics's net margin has grown at a 1.1% compound annual growth rate (CAGR), from -787% to -829.6%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.
Ask your AI about Aclaris Therapeutics's net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude